Phase II Trial of Avastin (Bevacizumab) in PSA Relapse Androgen Independent Prostate Cancer.

Trial Profile

Phase II Trial of Avastin (Bevacizumab) in PSA Relapse Androgen Independent Prostate Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2014

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 Aug 2012 Actual end date (1 Jun 2012) added as reported by ClinicalTrials.gov. (NCT00478413)
    • 10 Aug 2012 Actual end date (1 Jun 2012) added as reported by ClinicalTrials.gov. (NCT00478413)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top